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Background
Patients with left ventricular hypertrophy (LVH), typi-
cally assessed by 2D echocardiography, are at a greater
risk for heart failure and sudden cardiac death. An accu-
rate diagnosis of LVH is essential to clinical evaluation
and treatment. However, 2D echo has inferior spatial
resolution and less than optimal measurement position-
ing, relative to cardiac MRI. This “real-world” study,
based on finalized 2D echo reports, sought to compare
assessment of LVH on 2D echo to results by cardiac
MRI (cMRI).
Methods
All 1,255 patients in an institutional cardiac MRI data-
base were queried for a 2D echo study within 6 months
of the cMRI study. Patient 2D and cMRI reports were
then classified as either negative (no evidence of LVH
on the final report) or positive (evidence of LVH on the
final report). Antero-septal and infero-posterior LV wall
thickness dimensions were recorded for both imaging
modalities for all patients, and a paired-sample t-test
was used for statistical comparison.
Results
Six hundred twenty-four patients in the cMRI database
had both 2D echo and cMRI exams. Of these 624 patients,
280 patients had a diagnosis of LVH on the 2D echo
report. On 2D echo the mean antero-septal LV wall thick-
ness was 1.30 ± 0.20 cm, while on cMRI the mean antero-
septal LV wall thickness was 1.20 ± 0.31 cm (p<0.001). On
2D echo the mean infero-posterior LV wall thickness was
1.29 ± 0.17 cm, while comparatively the mean infero-pos-
terior LV wall thickness by cMRI was 0.94 ± 0.21 cm
(p<0.001). Of the 280 patients with a diagnosis of LVH on
the 2D echo report, the diagnosis of LVH was corrobo-
rated by cMRI in only 43 cases.
Conclusions
There is low concordance between a diagnosis of LVH
by 2D echo when compared to cMRI, as derived from
final imaging reports in an active clinical practice.
Because of better spatial resolution, less restricted view-
ing window and more accurate positioning of LV wall
thickness dimensions, cMRI may be a more appropriate
imaging modality for assessing left ventricular hypertro-
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